MORE►
CRISPR gene editing therapy
Medical City Children’s Hospital in Dallas [Photo: Medical City Healthcare]
Dallas’ Medical City Children’s To Offer New CRISPR Gene Editing Therapy for Sickle Cell Disease
by David Seeley | Dec 11, 2023
On Friday, the first CRISPR-based gene-editing therapy to win FDA approval was announced. CASGEVY holds "the potential of a functional cure" for sickle cell disease—and Medical City Children’s is one of only nine hospitals in the U.S. in its initial network of authorized treatment centers.
